Core Laboratories (CLB) Enterprise Value (2022 - 2026)

Core Laboratories' Enterprise Value history runs 5 years deep, the most recent figure standing at -$16.6 million for Q1 2026.

• On a quarterly basis, Enterprise Value fell 2.61% year-over-year to -$16.6 million in Q1 2026; TTM through Mar 2026 was -$16.6 million, a 2.61% decrease from a year earlier, with the FY2025 full-year figure at -$16.5 million, down 22.88% from the prior year.
• Enterprise Value steadied at -$16.6 million in Q1 2026 per CLB's latest filing, from -$16.5 million in the prior quarter.
• Across five years, Enterprise Value topped out at -$9.7 million in Q1 2024 and bottomed at -$25.2 million in Q2 2025.
• The 5-year median for Enterprise Value is -$15.8 million (2024), against an average of -$15.3 million.
• Across the five-year window, Enterprise Value surged 42.52% in 2024 and slumped 105.03% in 2025, its largest moves.
• Year by year, Enterprise Value stood at -$10.7 million in 2022, then grew by 5.63% to -$10.1 million in 2023, then tumbled by 32.42% to -$13.4 million in 2024, then declined by 22.88% to -$16.5 million in 2025, then retreated by 0.49% to -$16.6 million in 2026.
• Per Business Quant, the three latest CLB Enterprise Value figures stand at -$16.6 million (Q1 2026), -$16.5 million (Q4 2025), and -$19.6 million (Q3 2025).